WHO calls for sustainable solution to health sector power shortages in Gaza

8 February, 2018, Gaza Strip – Gaza’s health sector was on the verge of collapse due to dwindling fuel supplies until the United Arab Emirates stepped in this week with a US$2 million grant to sustain hospital backup generators for critical health services. The donation will provide enough fuel to keep facilities running for several months.  “The UAE’s timely support will save lives, but a more sustainable solution is required to address the chronic fuel and power shortages in Gaza that leave health facilities consistently on the verge of closure,” says Dr. Gerald Rockenschaub, Head of WHO’s Office for West Bank and Gaza.  Daily power cuts of 12-16 hours currently affect 28 hospitals and 153 primary care facilities in the Gaza Strip. The Ministry of Health has been rationing fuel supplies since January, when UN supplies for backup generators in 14 public hospitals drastically declined.  Between late January and early February 2018, two hospitals were forced to shut down: Durrah Hospital serving a catchment area of 250 000 people, and Gaza Psychiatric Hospital, the only mental health hospital in Gaza.  Beit Hanoun Hospital, a 63-bed hospital located in the northern Gaza, was also partially closed, with the Emergency Department functioning at minimal capacity.  Public hospitals in the Gaza Strip provide life-saving healthcare for 1715 patients every day – including 113 newborns, 100 patients in intensive car...
Source: WHO EMRO News - Category: Middle East Health Source Type: news

Related Links:

CONCLUSIONS: Serum PⅢNP could be a new biomarker for predicting the cardiovascular events in patients undergoing hemodialysis. PMID: 30111669 [PubMed - as supplied by publisher]
Source: Journal of Atherosclerosis and Thrombosis - Category: Cardiology Tags: J Atheroscler Thromb Source Type: research
Conditions:   Bacterial Infections;   Ceftazidime;   Renal Failure Chronic Requiring Hemodialysis Intervention:   Drug: Drug bood sampling Sponsors:   Centre Hospitalier Universitaire de Charleroi;   Université Catholique de Louvain Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Uremic Pruritus Interventions:   Drug: CR845 0.5 mcg/kg;   Drug: Placebo Sponsor:   Cara Therapeutics, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
We present the cases of eight patients (mean age 75 years; EuroSCORE II 17.0  ± 22.0) who underwent post-cardiotomy venovenous extracorporeal membrane oxygenation (ECMO) without heparinization due to serious bleeding. Three liver cirrhosis, two chronic hemodialysis, three redo sternotomy, and two urgent surgery cases were included. Respiratory ECMO Survival Prediction s core was − 5.1 ± 4.2 (estimated survival rate: approximately 30%). Mean ECMO duration was 14 days with 9 circuit exchanges. Five patients were weaned from ECMO and three were discharged alive at 90...
Source: General Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
CONCLUSIONS: Iron cessation in chronic hemodialysis patients with high ferritin levels did not affect hemoglobin level or ESA dose and can be considered as a safe policy for attenuating the risk of chronic iron overload. PMID: 30109787 [PubMed - in process]
Source: The Israel Medical Association Journal - Category: General Medicine Tags: Isr Med Assoc J Source Type: research
ConclusionsOutcomes of a second fistula may be inferior to outcomes of the initial fistula. First and second fistula outcomes are weakly correlated and difficult to predict based on clinical characteristics.
Source: American Journal of Kidney Diseases - Category: Urology & Nephrology Source Type: research
Conditions:   Secondary Hyperparathyroidism;   Chronic Kidney Disease Intervention:   Drug: Etelcalcetide Sponsor:   Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Hemolysis;   Cannulation;   Arteriovenous Fistula;   Nurse's Role Intervention:   Procedure: nurse assistance for home hemodialysis Sponsors:   University Hospital, Caen;   NxStage Medical Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Secondary Hyperparathyroidism;   Chronic Kidney Disease Intervention:   Drug: Etelcalcetide Sponsor:   Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Hemolysis;   Cannulation;   Arteriovenous Fistula;   Nurse's Role Intervention:   Procedure: nurse assistance for home hemodialysis Sponsors:   University Hospital, Caen;   NxStage Medical Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Dialysis | Emergency Medicine | Grants | Hemodialysis | Hospitals | Intensive Care | Men | Middle East Health | OBGYN | Primary Care | Psychiatry | UAE Health | Women